The Burrill Report (October 11, 2010): Emerging Biotechs Grapple with Financing Challenges (.MP3,10.12 Mb)
Despite the improved economic environment compared to a year ago, the mood seemed a tad glum at this year’s BIO Investor Forum as relief about the worst of the financial downturn being over has given way to the reality of a prolonged period of financing challenges for emerging biotechs. We spoke to Rachel King, CEO of GlycoMimetics and former chair of the Biotechnology Industry Organization’s Emerging Companies Governing Body. We discussed the financial challenges biotech’s face, the changing demands from venture investors, and what a company needs to do today to ensure it has adequate financing to be successful.
October 08, 2010
http://www.burrillreport.com/article-emerging_biotechs_grapple_with_financing_challenges_.html